[Antidose therapy for organophosphate poisoning].
Ken
K
Iseki
D000931:Antidotes / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002801:Cholinesterase Reactivators / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D062025:Organophosphate Poisoning; D010575:Pesticides / Q000506:poisoning*; D011220:Pralidoxime Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D010575:Pesticides; D011220:Pralidoxime Compounds; D001285:Atropine; C028797:pralidoxime